Proximus (BGAOY) Short Interest Ratio & Short Volume → **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad) Free BGAOY Stock Alerts $1.55 +0.03 (+1.97%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesSEC FilingsShort Interest Proximus Short Interest DataCurrent Short Interest2,500 sharesPrevious Short Interest1,600 sharesChange Vs. Previous Month+56.25%Dollar Volume Sold Short$3,875.00Short Interest Ratio2.3 Days to CoverLast Record DateApril 15, 2024Today's Trading Volume7,200 sharesAverage Trading Volume9,776 sharesToday's Volume Vs. Average74% Short Selling Proximus ? Sign up to receive the latest short interest report for Proximus and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBGAOY Short Interest Over TimeBGAOY Days to Cover Over TimeBGAOY Percentage of Float Shorted Over Time Ad Huge Alerts**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report Proximus Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,500 shares $3,875.00 +56.3%N/A2.3 $1.55 3/31/20241,600 shares $2,528.00 -86.8%N/A4 $1.58 3/15/202412,100 shares $19,577.80 +266.7%N/A3.9 $1.62 2/29/20243,300 shares $5,379.00 +3.1%N/A33 $1.63 2/15/20243,200 shares $5,696.00 +3.2%N/A10.7 $1.78 1/15/20243,100 shares $6,107.00 +47.6%N/A10.3 $1.97 Get the Latest News and Ratings for BGAOY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Proximus and its competitors with MarketBeat's FREE daily newsletter. 12/31/20232,100 shares $3,853.50 No ChangeN/A4.9 $1.84 12/15/20232,100 shares $3,832.50 No ChangeN/A0.4 $1.83 11/30/20232,100 shares $4,155.48 No ChangeN/A7 $1.98 11/15/20232,100 shares $3,547.95 +75.0%N/A5.3 $1.69 10/31/20231,200 shares $1,944.00 +1,100.0%N/A2 $1.62 10/15/2023100 shares $157.00 No ChangeN/A1 $1.57 9/30/2023100 shares $157.00 No ChangeN/A0.2 $1.57 9/15/2023100 shares $154.11 No ChangeN/A0.1 $1.54 8/31/2023100 shares $134.60 -50.0%N/A0 $1.35 8/15/2023200 shares $290.00 -80.0%N/A0 $1.45 7/31/20231,000 shares $1,500.00 -80.4%N/A0.3 $1.50 7/15/20235,100 shares $8,007.00 +920.0%N/A2 $1.57 6/30/2023500 shares $715.15 No ChangeN/A0.1 $1.43 5/31/20231,300 shares $2,054.00 +160.0%N/A0.7 $1.58 5/15/2023500 shares $825.00 No ChangeN/A0.2 $1.65 4/30/2023500 shares $872.25 -83.9%N/A0 $1.74 4/15/20233,100 shares $6,169.00 -54.4%N/A0.6 $1.99 3/31/20236,800 shares $12,852.00 -17.1%N/A3.8 $1.89 3/15/20238,200 shares $13,981.00 -5.8%N/A11.7 $1.71 2/28/20238,700 shares $15,834.00 +47.5%N/A6.2 $1.82 2/15/20235,900 shares $11,534.50 No ChangeN/A7.4 $1.96 1/31/20235,900 shares $11,682.00 No ChangeN/A11.8 $1.98 1/15/20235,900 shares $11,918.00 -20.3%N/A2.6 $2.02 12/30/20227,400 shares $13,912.00 +13.9%N/A1.8 $1.88 12/15/20226,500 shares $11,765.00 +38.3%N/A0.8 $1.81 11/30/20224,700 shares $9,494.00 -88.7%N/A0.1 $2.02 11/15/202241,600 shares $93,184.00 +75.5%N/A3.9 $2.24 10/31/202223,700 shares $49,296.00 +1,085.0%N/A1.4 $2.08 10/15/20222,000 shares $3,420.00 -77.0%N/A0.1 $1.71 9/30/20228,700 shares $17,052.00 -62.2%N/A0.5 $1.96 9/15/202223,000 shares $51,060.00 +152.8%N/A1.4 $2.22 8/31/20229,100 shares $22,932.00 +12.4%N/A0.9 $2.52 8/15/20228,100 shares $21,546.00 +125.0%N/A1 $2.66 7/31/20223,600 shares $9,738.00 +125.0%N/A0.5 $2.71**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 7/15/20221,600 shares $4,384.00 +60.0%N/A0.3 $2.74 6/30/20221,000 shares $2,840.00 No ChangeN/A0.2 $2.84 3/31/20221,300 shares $4,719.00 +85.7%N/A0.9 $3.63 3/15/2022700 shares $2,548.00 +16.7%N/A0.1 $3.64 2/28/2022600 shares $2,367.00 No ChangeN/A0.3 $3.95 11/30/2021100 shares $357.00 -88.9%N/A0 $3.57 11/15/2021900 shares $3,447.00 +200.0%N/A0.2 $3.83 10/29/2021300 shares $1,126.80 No ChangeN/A0.4 $3.76 10/15/2021300 shares $1,194.00 No ChangeN/A0.2 $3.98 9/30/2021300 shares $1,179.00 No ChangeN/A0.2 $3.93 7/15/20211,700 shares $6,630.00 -58.5%N/A0.9 $3.90 6/30/20214,100 shares $15,785.00 +355.6%N/A1.2 $3.85 6/15/2021900 shares $3,735.00 -30.8%N/A0.3 $4.15 5/28/20211,300 shares $5,278.00 +225.0%N/A1.6 $4.06 5/14/2021400 shares $1,628.00 -98.0%N/A0.1 $4.07 4/30/202119,600 shares $84,672.00 +1,533.3%N/A4.4 $4.32 4/15/20211,200 shares $5,364.00 -79.0%N/A0.9 $4.47 3/31/20215,700 shares $25,422.00 +470.0%N/A2.3 $4.46 3/15/20211,000 shares $4,020.00 -47.4%N/A0.2 $4.02 2/26/20211,900 shares $8,322.00 +375.0%N/A0.7 $4.38 2/12/2021400 shares $1,660.00 No ChangeN/A0.1 $4.15 1/29/2021400 shares $1,704.00 No ChangeN/A0.2 $4.26 1/15/20212,300 shares $9,545.00 -76.0%N/A0.6 $4.15 12/31/20203,200 shares $12,480.00 +39.1%N/A1.8 $3.90 12/15/20202,300 shares $9,637.00 -76.0%N/A0.6 $4.19 11/30/20209,600 shares $40,540.80 +50.0%N/A1.8 $4.22 11/15/20206,400 shares $26,048.00 +433.3%N/A0.9 $4.07 10/30/20201,200 shares $4,224.00 -73.9%N/A0.2 $3.52 10/15/20204,600 shares $17,848.00 -75.7%N/A1.5 $3.88 9/30/202018,900 shares $67,189.50 No ChangeN/A1.8 $3.56 8/31/20203,600 shares $14,184.00 +24.1%N/A0.5 $3.94 8/14/20202,900 shares $11,788.50 -27.5%N/A0.7 $4.07 7/31/20204,000 shares $16,440.00 +1,900.0%N/A1.7 $4.11 7/15/2020200 shares $844.00 -87.5%N/A0 $4.22 6/30/20201,600 shares $6,401.60 -38.5%N/A0.6 $4.00 6/15/20202,600 shares $10,946.00 -35.0%N/A0.2 $4.21 5/29/20204,000 shares $16,324.00 No ChangeN/A0.9 $4.08 4/30/20201,500 shares $6,375.00 No ChangeN/A0.3 $4.25 3/13/20207,900 shares $28,835.00 +107.9%N/A2.5 $3.65 2/28/20203,800 shares $17,936.00 -30.9%N/A1.2 $4.72 2/14/20205,500 shares $31,088.75 +61.8%N/A5.5 $5.65 1/31/20203,400 shares $16,592.00 +79.0%N/A8.5 $4.88 1/15/20201,900 shares $10,602.00 +5.6%N/A4.8 $5.58 12/31/20191,800 shares $9,990.00 +38.5%N/A3 $5.55 BGAOY Short Interest - Frequently Asked Questions What is Proximus' current short interest? Short interest is the volume of Proximus shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 2,500 shares of BGAOY short. Learn More on Proximus' current short interest. What is a good short interest ratio for Proximus? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BGAOY shares currently have a short interest ratio of 2.0. Learn More on Proximus's short interest ratio. Is Proximus' short interest increasing or decreasing? Proximus saw a increase in short interest in April. As of April 15th, there was short interest totaling 2,500 shares, an increase of 56.3% from the previous total of 1,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Proximus stock? Short selling BGAOY is an investing strategy that aims to generate trading profit from Proximus as its price is falling. BGAOY shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Proximus? A short squeeze for Proximus occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BGAOY, which in turn drives the price of the stock up even further. How often is Proximus' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BGAOY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ALVRQ Short Interest BZQIY Short Interest BZQIF Short Interest BTGOF Short Interest CHWRF Short Interest CGEAF Short Interest CGECF Short Interest COMSW Short Interest ELMUF Short Interest FULO Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BGAOY) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsUrgent Nvidia WarningAltimetryThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts